JN

Jaymala Namdev Shilwant

Active Director Director DIN 09865514
DIN 09865514 First appointment Jan 2023 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Jaymala Namdev Shilwant

Data last updated:

Jaymala Namdev Shilwant is a Director at Healing Dew Pharma Private Limited (since 2023). The company operates in Food And Beverages.

DIN 09865514
Primary Designation Director
Industry Food And Beverages
First Appointment 20 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Healing Dew Pharma Private Limited U24304MH2023PTC398069
Director20 Jan 20232023Active

Board colleagues of Jaymala Namdev Shilwant

NameDINCompanyDesignation
Nitin Ashok Pawar09865513Healing Dew Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Healing Dew Pharma Private Limited
Premium access

Shareholding and investment profile for Jaymala Namdev Shilwant

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaymala Namdev Shilwant

Jaymala Namdev Shilwant currently holds 1 directorship: Healing Dew Pharma Private Limited (Director, since 20 Jan 2023).

Jaymala Namdev Shilwant was first appointed on 20 Jan 2023 as Director at Healing Dew Pharma Private Limited.

The current boards of Jaymala Namdev Shilwant's companies include Nitin Ashok Pawar (Healing Dew Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available